Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
作者： Jean-Pierre Pignon , Aurélie le Maître , Emilie Maillard , Jean Bourhis
DOI: 10.1016/J.RADONC.2009.04.014
关键词: Head and neck cancer 、 Chemotherapy 、 Hazard ratio 、 DAHANCA 、 Oncology 、 Internal medicine 、 Induction chemotherapy 、 Head and neck squamous-cell carcinoma 、 Medicine 、 Radiation therapy 、 Concomitant
摘要: BACKGROUND: Our previous individual patient data (IPD) meta-analysis showed that chemotherapy improved survival in patients curatively treated for non-metastatic head and neck …
core.ac.uk
elsevier.com
sci-hub.se 参考文章(19)
Early Breast Cancer Trialist's Collaborative Group, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. The Lancet. ,(1992) , 10.1016/0140-6736(92)90997-H
Salim Yusuf, Richard Peto, John Lewis, Rory Collins, Peter Sleight, Beta blockade during and after myocardial infarction: An overview of the randomized trials Progress in Cardiovascular Diseases. ,vol. 27, pp. 335- 371 ,(1985) , 10.1016/S0033-0620(85)80003-7
J.P Pignon, J Bourhis, C Domenge, L Designe, Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer Cancer Radiotherapie. ,vol. 5, pp. 201- 202 ,(2001) , 10.1016/S1278-3218(00)00073-1
Michael Schemper, Terry L. Smith, A note on quantifying follow-up in studies of failure time Controlled Clinical Trials. ,vol. 17, pp. 343- 346 ,(1996) , 10.1016/0197-2456(96)00075-X
Jean-Pierre Pignon, Aurélie le Maître, Jean Bourhis, Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. International Journal of Radiation Oncology Biology Physics. ,vol. 69, ,(2007) , 10.1016/J.IJROBP.2007.04.088
Jan B. Vermorken, Eva Remenar, Carla van Herpen, Thierry Gorlia, Ricard Mesia, Marian Degardin, John S. Stewart, Svetislav Jelic, Jan Betka, Joachim H. Preiss, Danielle van den Weyngaert, Ahmad Awada, Didier Cupissol, Heinz R. Kienzer, Augustin Rey, Isabelle Desaunois, Jacques Bernier, Jean-Louis Lefebvre, Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. The New England Journal of Medicine. ,vol. 357, pp. 1695- 1704 ,(2007) , 10.1056/NEJMOA071028
Bertrand Baujat, Cédric Mahé, Jean-Pierre Pignon, Catherine Hill, A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Statistics in Medicine. ,vol. 21, pp. 2641- 2652 ,(2002) , 10.1002/SIM.1221
Joseph B. Weissberg, Yung H. Son, Rose J. Papac, Clarence Sasaki, Diana B. Fischer, Roberta Lawrence, Sara Rockwell, Alan C. Sartorelli, James J. Fischer, Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. International Journal of Radiation Oncology Biology Physics. ,vol. 17, pp. 3- 9 ,(1989) , 10.1016/0360-3016(89)90362-3
Julian P. T. Higgins, Simon G. Thompson, Quantifying heterogeneity in a meta‐analysis Statistics in Medicine. ,vol. 21, pp. 1539- 1558 ,(2002) , 10.1002/SIM.1186
Ricardo Hitt, Antonio López-Pousa, Javier Martínez-Trufero, Vicente Escrig, Joan Carles, Alfredo Rizo, Dolores Isla, M. Eugenia Vega, Juan L. Martí, Francisco Lobo, Pedro Pastor, Vicente Valentí, Joaquín Belón, Miguel A. Sánchez, Carlos Chaib, Cinta Pallarés, Antonio Antón, Andrés Cervantes, Luis Paz-Ares, Hernán Cortés-Funes, Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer Journal of Clinical Oncology. ,vol. 23, pp. 8636- 8645 ,(2005) , 10.1200/JCO.2004.00.1990